Hormones
Research from Emory University in hormones provides new insights
Published in Women's Health Weekly, May 28th, 2009
According to recent research from the United States, "The Women's Health Initiative trials - in which more extreme adverse outcomes were observed in the medroxyprogesterone acetate (MPA) + conjugated equine estrogen (CEE) arm, as compared to the CEE only arm - suggest that the addition of MPA to estrogen treatment has undesirable consequences. An important question raised by these results is whether the adverse outcomes observed in the progestin arm can be attributed to effects that are unique to MPA or are common to all progestins."
"In this study we explored the potential for MPA and progesterone (P4) to differentially impact neuroendocrine function by comparing their...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- American Dietetic Association
ADA releases position paper on obesity, reproduction and pregnancy outcomes - American Psychological Association
Cognition already seriously impaired in first episode of schizophrenia - BioMed Central
Stigma increases likelihood that drug users reoffend - European Society of Cardiology
Massive decline in rates of coronary death in Iceland are largely attributed to risk factor reductions in the population - Journal of the National Cancer Institute
Women diagnosed with precancerous CIN at risk for cervical cancer - McGill University Health Centre
Equality of the sexes? Not always when it comes to biology - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
